Sepsitron Company

Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.
Technology: Biomarkers
Industry: Hardware, Medical Device
Headquarters: Singapore
Founded Date: 11-1
Employees Number: 43840
Funding Status: Seed
Total Funding: 6-21
Last Funding Date: 43913
Last Funding Type: Pre-Seed

Visit Website
Register and Claim Ownership